What users say
0 votes
Usefulness
No data
0 votes
Value for Cost
No data
0 votes
Support
No data
0 votes
Pricing
No data
0 votes
Learning Curve
No data
0 votes
Paid on Platform
No data
0 votes
Rate this Tool
Related Moonlites
Related Creators
Related Education
Recursion is a clinical-stage biotechnology company that combines artificial intelligence, automation, and wet lab biology to accelerate drug discovery and development. The platform uses machine learning to analyze massive datasets of biological images and molecular data to identify novel therapeutic targets and predict drug efficacy. Recursion operates one of the world largest biological dataset with over 23 petabytes of proprietary biological and chemical data. Key features include high-throughput cellular imaging and analysis, AI-powered phenotypic drug discovery, automated wet lab biology systems, predictive modeling for drug development, and comprehensive databases of biological and chemical interactions. The platform enables pharmaceutical companies to discover new drugs faster and more cost-effectively than traditional methods. Popular among pharmaceutical companies, biotechnology firms, drug development researchers, and investors seeking innovative approaches to therapeutic discovery and development.
About
Recursion is a clinical-stage biotechnology company that combines artificial intelligence, automation, and wet lab biology to accelerate drug discovery and development. The platform uses machine learning to analyze massive datasets of biological images and molecular data to identify novel therapeutic targets and predict drug efficacy. Recursion operates one of the world largest biological dataset with over 23 petabytes of proprietary biological and chemical data. Key features include high-throughput cellular imaging and analysis, AI-powered phenotypic drug discovery, automated wet lab biology systems, predictive modeling for drug development, and comprehensive databases of biological and chemical interactions. The platform enables pharmaceutical companies to discover new drugs faster and more cost-effectively than traditional methods. Popular among pharmaceutical companies, biotechnology firms, drug development researchers, and investors seeking innovative approaches to therapeutic discovery and development.